Confronting Pain Management and the Opioid Epidemic


In response to the opioid epidemic, the US Food and Drug Administration (FDA) commissioned the National Academies of Sciences, Engineering, and Medicine to form a committee to update its 2011 report Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. The goal was for the committee to address the role of opioids in pain management, review the epidemiology of the opioid epidemic and the strategies to address it, and to identify actions that FDA and other government offices and organizations can take to address it.

There was a also a focus on identifying the individual and society-level considerations in developing a “risk-benefit framework for opioid approval and monitoring.” The findings of the committee are presented in a new report from the National Academies.

Read the report.